NA
PRPH

Navellier & Associates’s ProPhase Labs PRPH Stock Holding History

Navellier & Associates’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,857
Closed -$446K – 296
2023
Q1 		$446K Sell
5,857
-1,382
-19% -$111K 0.09% 192
2022
Q4 		$697K Buy
7,239
+3,217
+80% +$348K 0.14% 137
2022
Q3 		$454K Buy
+4,022
New +$468K 0.1% 167

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return

Navellier & Associates's PRPH Position: Q2 2023 in Review

Navellier & Associates sold out of ProPhase Labs (PRPH) in Q2 2023, closing a stake of 5,857 shares — an estimated $446K sold.

Navellier & Associates first reported a position in PRPH in Q3 2022 and held it in 3 quarters. The position peaked at $697K in Q4 2022. 45 funds tracked by Wall St. Rank hold PRPH as of Q2 2023.

  • Navellier & Associates reported no remaining ProPhase Labs position as of Q2 2023 after selling out during the quarter.
  • Navellier & Associates sold 5,857 ProPhase Labs shares in Q2 2023, an estimated $446K.
  • Navellier & Associates first reported a position in ProPhase Labs in Q3 2022 and held it in 3 quarters.
  • Navellier & Associates's ProPhase Labs position peaked at $697K in Q4 2022.
  • 45 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2023.

Based on Navellier & Associates's 13F filing for Q2 2023, filed 7 Aug 2023.